SCHEMBL24325675

SCHEMBL24325675

CCC(CC)c1nc(-c2ccc(C)cc2)no1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 10/20 0.53
RAB9A P51151 9/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
SMN1; SMN2 Q16637 11/20 0.50
L3MBTL1 Q9Y468 5/20 0.50
NFKB1 P19838 3/20 0.50
NFKB2 Q00653 3/20 0.50
RELA Q04206 3/20 0.50
TSHR P16473 2/20 0.50
MAPK1 P28482 2/20 0.50
ALDH1A1 P00352 1/20 0.50
LMNA P02545 1/20 0.50
TDP1 Q9NUW8 3/20 0.49
NPSR1 Q6W5P4 2/20 0.49
S1PR1 P21453 1/20 0.49
NR1H4 Q96RI1 1/20 0.49
MAPT P10636 2/20 0.46
TP53 P04637 2/20 0.46
ATM Q13315 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14153100 0.85 S1PR1 (0.62) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL26524272 0.85 S1PR1 (0.48) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL14060225 0.85 RAB9A (0.53) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL19091431 0.85 S1PR1 (0.61) NPC1RAB9ASMN1; SMN2L3MBTL1NFKB1
SCHEMBL19090054 0.85 S1PR1 (0.66) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL28869645 0.84 NPC1 (0.50) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL19091255 0.83 MAPT (0.48) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL12188525 0.81 SMN1; SMN2 (0.57) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL28869613 0.79 NPC1 (0.56) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL21332420 0.79 NPC1 (0.58) NPC1RAB9AMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022056042-A1 INHIBITORS OF SPINSTER HOMOLOG 2 (SPNS2) FOR USE IN THERAPY UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2022-03-17 WO disclosed